| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/18/2004 | CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal |
| 02/18/2004 | CN1138591C Coated particles, method of making and using |
| 02/18/2004 | CN1138550C Process of producing extracts of shark |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/18/2004 | CN1138539C Use of basic amino acids and derivatives for lowering ceramide levels |
| 02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693183 MURINE α (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 02/17/2004 | US6693135 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 02/17/2004 | US6693133 Methods of cardioprotection using dichloroacetate in combination with an inotrope |
| 02/17/2004 | US6693129 A biochemical formulation comprising ascorbic acid, niacin, lysine, and proline useful for lowering plasma concentration of a lipoprotein in mammal |
| 02/17/2004 | US6693127 Pharmaceutical compositions of arglabin and arglabin derivatives |
| 02/17/2004 | US6693121 As inhibitors of serine proteases of the coagulation cascade and compounds, used for anticoagulant therapy forprophylaxis of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 02/17/2004 | US6693112 Compounds for enhancing chemotherapy |
| 02/17/2004 | US6693102 Pyridine-substituted pyrazolopyridine derivatives |
| 02/17/2004 | US6693101 Alkanoic acid derivative; integrin receptor antagonist |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693083 Intracellular drug delivery into an interleukin-2 receptor-bearing cell includes a chemical agent and a copy of an interleukin-2-receptor binding and endocytosis-inducing ligand bound to a water soluble polymer |
| 02/17/2004 | US6693079 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693078 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692753 Potentiation of the immune response |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/17/2004 | CA2290918C Heteroaromatic bicyclic derivatives useful as anticancer agents |
| 02/17/2004 | CA2249299C Combination of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum |
| 02/12/2004 | WO2004013629A2 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013306A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013174A1 Use of disease-associated gene |
| 02/12/2004 | WO2004013145A1 Pyrrolotriazine kinase inhibitors |
| 02/12/2004 | WO2004013144A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | WO2004013140A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 02/12/2004 | WO2004013137A1 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
| 02/12/2004 | WO2004013110A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazoliniones useful as hiv reverse transcriptase inhibitors |
| 02/12/2004 | WO2004012791A2 Improved injection system |
| 02/12/2004 | WO2004012769A1 Therapeutic inhibitionof protein kinases in cancer cells |
| 02/12/2004 | WO2004012768A1 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and/or a mtor inhibitor |
| 02/12/2004 | WO2004012767A1 Medicinal agent and method for curing erectile dysfunction |
| 02/12/2004 | WO2004012766A1 Method for correcting immune responses and medicinal agent |
| 02/12/2004 | WO2004012749A1 An analgesic agent for newborn or fetal subjects |
| 02/12/2004 | WO2004012744A1 Use of alkyl phosphocholines in combination with antitumor medicaments |
| 02/12/2004 | WO2004012740A1 MEDICINAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR |
| 02/12/2004 | WO2004012732A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 02/12/2004 | WO2004012728A1 Combination of an aromatase inhibitor with a bisphosphonate |
| 02/12/2004 | WO2004012719A1 Improved transdermal delivery system |
| 02/12/2004 | WO2004012704A1 Antibiotic product, use and formulation thereof |
| 02/12/2004 | WO2004012669A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 02/12/2004 | WO2004012662A2 Improved treatment of cancer with glutamine |
| 02/12/2004 | WO2004012659A2 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 02/12/2004 | WO2004012503A2 Compositions comprising muscle progenitor cells and uses thereof |
| 02/12/2004 | WO2003094957A3 Methods of therapy for inducing tolerance |
| 02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
| 02/12/2004 | WO2003088909A3 Methods for modulating phototoxicity |
| 02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
| 02/12/2004 | WO2003086041A3 Binding agents and their use in targeting tumor cells |
| 02/12/2004 | WO2003084473A3 Method of treating cancer |
| 02/12/2004 | WO2003079885A3 Inhalable sustained therapeutic formulations |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003065994A3 Schwann cell and phosphodiesterase inhibitors based therapy |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003057136A3 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| 02/12/2004 | WO2003051346A3 Use of selective pde5 inhibitors for treating partial and global respiratory failure |
| 02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
| 02/12/2004 | WO2003050301A3 Susceptibility locus for schizophrenia |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003044524A3 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 02/12/2004 | WO2003039404A3 Methods for treating ocular neovascular diseases |
| 02/12/2004 | WO2003034996B1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003029209A3 Chemical compounds |
| 02/12/2004 | WO2003013424A3 Use of r-nsaid compounds for anti-hiv treatment |
| 02/12/2004 | WO2003008365A3 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2002101357A9 Molecular signatures of commonly fatal carcinomas |
| 02/12/2004 | WO2002094196A3 Method of treatment for cancers associated with elevated |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002053580A3 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 02/12/2004 | WO2002030406A3 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 02/12/2004 | US20040030248 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 02/12/2004 | US20040030165 14 Beta, 16, 17-methylene steroids as novel androgens |
| 02/12/2004 | US20040030118 Methods for regulating hematopoiesis using CpG-oligonucleotides |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040030033 New film coating |
| 02/12/2004 | US20040029975 Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds |
| 02/12/2004 | US20040029972 Synergistic mixtuyre of antidepressant and serotonine receptor antagonist; psychological disorders; sexual disorders |
| 02/12/2004 | US20040029970 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029953 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029941 Zonisamide use in obesity and eating disorders |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029906 Antiproliferative agents; anticancer agents |